Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-25-002600·Jasper Therapeutics, Inc.
Schedule 13D ownership disclosure
JASPER THERAPEUTICS INC
Voting Common Stock, par value $0.0001 per share · CUSIP: 471871202
Event date: 2025-09-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Velan Capital Master Fund LPReported CIK 0001964356
Shares: 2,381,915.00 · Class: 8.5%
- Velan Capital Holdings LLCReported CIK 0001964353
Shares: 2,381,915.00 · Class: 8.5%
- Velan Horizon Fund LPReported CIK 0002057740
Shares: 41,152.00 · Class: 0.1%
- Velan Horizon GP LLCReported CIK 0002057821
Shares: 41,152.00 · Class: 0.1%
- Avego Healthcare Capital, L.P.Reported CIK 0001822834
Shares: 245,328.00 · Class: 0.9%
- Avego Healthcare Capital Holdings, LLCReported CIK 0001964446
Shares: 245,328.00 · Class: 0.9%
- Avego Management LLCReported CIK 0001886177
Shares: 245,328.00 · Class: 0.9%
- Velan Capital Investment Management LPReported CIK 0001848809
Shares: 2,668,395.00 · Class: 9.6%
- Velan Capital Management LLCReported CIK 0001964355
Shares: 2,668,395.00 · Class: 9.6%
- Morgan AdamReported CIK 0001964335
Shares: 2,668,395.00 · Class: 9.6%
- VENKATARAMAN BALAJIReported CIK 0001114916
Shares: 2,668,395.00 · Class: 9.6%
- Kapoor VishalReported CIK 0001798946
Shares: 23,867.00 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002600
- Form type
- SCHEDULE 13D/A
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Sep 23, 2025
- Reporting period
- Sep 19, 2025
- Description
- Schedule 13D beneficial ownership